Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Canada (TSX) (EWC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance

iShares MSCI Canada (TSX)Trade
Halozyme Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Canada (TSX) vs Halozyme Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Canada (TSX) trades at $58.86 (market cap $6.99B), while Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Canada (TSX) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Canada (TSX) for 57 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.

EWCHALO
Market Cap
$6.99B$12.58B
Volume
1,625,8472,179,278
Sector
Broad Market / FactorHealth
52-Week High
$62.64$115.22
52-Week Low
$49.72$61.63
Typical Hold Time
57 Days0 Days
Enterprise Value
—$14.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Canada (TSX)

EWC trades at $57.94, down 2.1% today amid a bearish technical signal with moving averages indicating selling pressure. The stock lacks disclosed financial ratios, limiting fundamental clarity. Recent news highlights trade tensions between the U.S. and Canada, with potential impacts on cross-border economic activity and market sentiment.

The outlook is clouded by geopolitical risks from U.S.-Canada trade disputes, which could pressure performance. Investment opportunities hinge on resolution of trade frictions and improved economic data. Key risks include prolonged trade uncertainty and volatility from political developments.

Halozyme Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWC
90% Buy10% Sell
Avg holding period · 57 Days
HALO
100% Buy0% Sell
Avg holding period · 0 Days

About iShares MSCI Canada (TSX)

EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.

Read more on EWC →

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →